✦ LIBER ✦

Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism

✍ Scribed by Tetsuhiko Sato; Yoshihiro Tominaga; Tsuneo Ueki; Norihiko Goto; Susumu Matsuoka; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Shohei Nakanishi; Junichiro James Kazama; Fumitake Gejyo; Takeyoshi Yamashita; Masafumi Fukagawa

Book ID: 114466731
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 574 KB
Volume: 44
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2004.05.026

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Circulating Fibroblast Growth Fa

Role of Circulating Fibroblast Growth Factor 23 in the Development of Secondary Hyperparathyroidism

✍ Junichiro J Kazama; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

Possible involvement of circulating fibr

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency

✍ Takashi Shigematsu; Junichiro James Kazama; Takeyoshi Yamashita; Seiji Fukumoto; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Changes in fibroblast growth factor 23 d

Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol

✍ Hansen, D.; Rasmussen, K.; Pedersen, S. M.; Rasmussen, L. M.; Brandi, L. 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 312 KB

Calcitriol and doxercalciferol are equiv

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

✍ Wesseling-Perry, Katherine; Pereira, Renata C; Sahney, Shobha; Gales, Barbara; W 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 337 KB